NEW ORAL ANTICOAGULANTS FOR ATRIAL FIBRILLATION
Abstract: Atrial fibrillation
(AF) is the most common cardiac arrhythmia in the world. Four new oral
anticoagulants have become available as alternatives for warfarin in patients
with AF. Although the newer aspects have higher acquisition cost, the benefits
of cost savings may be derived from potential for decreasing the bleeding
incidence and reducing the need for anticoagulation monitoring.
Keywords: Atrial
fibrillation,anticoagulants
Author: Yuliana Yakobus
Journal Code: jpkedokterangg170272
